Skip to main content
SpringerLink
Log in
Book cover

Surgical Intensive Care Medicine pp 437–447Cite as

Evaluation of the Febrile Patient in the Intensive Care Unit

  • Chapter

Abstract

Body temperature elevation in critically ill patients is a frequent phenomenon that is typically the result of the systemic inflammatory response syndrome. In nearly one half of the cases, this is the result of an infectious process that often mandates an operative intervention and/or immediate antibiotic therapy. Other less common etiologies such as organ ischemia, thrombosis, and medications must also be considered in the differential diagnosis because they too require specific diagnostic studies and therapeutic management.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Mackowiak PA, Wasserman SS, Levine MM. A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA. 1992;268:1578–80.

    Article  CAS  PubMed  Google Scholar 

  2. Launey Y, Nesseler N, Malledant Y, Seguin P. Clinical review: fever in septic ICU patients—friend or foe? Crit Care. 2011;15:222.

    Article  PubMed  PubMed Central  Google Scholar 

  3. O’Grady NP, Barie PS, Bartlett J, Bleck T, Garvey G, Jacobi J, et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med. 1998;26:392–408.

    Article  PubMed  Google Scholar 

  4. Dimopoulos G, Falagas ME. Approach to the febrile patient in the ICU. Infect Dis Clin North Am. 2009;23:471–84.

    Article  PubMed  Google Scholar 

  5. Laupland KB. Fever in the critically ill medical patient. Crit Care Med. 2009;37:S273–8.

    Article  PubMed  Google Scholar 

  6. Misset B, De Jonghe B, Bastuji-Garin S, Gattolliat O, Boughrara E, Annane D, et al. Mortality of patients with heatstroke admitted to intensive care units during the 2003 heat wave in France: a national multiple-center risk-factor study. Crit Care Med. 2006;34:1087–92.

    Article  PubMed  Google Scholar 

  7. Cavaillon JM. Good and bad fever. Crit Care. 2012;16:119.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Blatteis CM. Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol Ther. 2006;111:194–223.

    Article  CAS  PubMed  Google Scholar 

  9. Saper CB, Breder CD. The neurologic basis of fever. N Engl J Med. 1994;330:1880–6.

    Article  CAS  PubMed  Google Scholar 

  10. Mackowiak PA, Boulant JA. Fever’s glass ceiling. Clin Infect Dis. 1996;22:525–36.

    Article  CAS  PubMed  Google Scholar 

  11. Blatteis CM, Sehic E, Li S. Pyrogen sensing and signaling: old views and new concepts. Clin Infect Dis. 2000;31 Suppl 5:S168–77.

    Google Scholar 

  12. Arend WP, Joslin FG, Massoni RJ. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol. 1985;134:3868–75.

    CAS  PubMed  Google Scholar 

  13. Mickenberg ID, Snyderman R, Root RK, Mergenhagen SE, Wolff SM. The relationship of complement consumption to immune fever. J Immunol. 1971;107:1466–76.

    CAS  PubMed  Google Scholar 

  14. Philippart F, Cavaillon JM. Sepsis mediators. Curr Infect Dis Rep. 2007;9:358–65.

    Article  PubMed  Google Scholar 

  15. Dinarello CA, Bernheim HA, Duff GW, Le HV, Nagabhushan TL, Hamilton NC, et al. Mechanisms of fever induced by recombinant human interferon. J Clin Invest. 1984;74:906–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986;163:1433–50.

    Article  CAS  PubMed  Google Scholar 

  17. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med. 1993;328:106–13.

    Article  CAS  PubMed  Google Scholar 

  18. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491–503.

    Article  CAS  PubMed  Google Scholar 

  19. Blatteis CM, Bealer SL, Hunter WS, Llanos QJ, Ahokas RA, Mashburn Jr TA. Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs. Brain Res Bull. 1983;11:519–26.

    Article  CAS  PubMed  Google Scholar 

  20. Blatteis CM, Hales JR, McKinley MJ, Fawcett AA. Role of the anteroventral third ventricle region in fever in sheep. Can J Physiol Pharmacol. 1987;65:1255–60.

    Article  CAS  PubMed  Google Scholar 

  21. Boulant JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis. 2000;31 Suppl 5:S157–61.

    Google Scholar 

  22. Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood–brain barrier. Neuroimmunomodulation. 1995;2:241–8.

    Article  CAS  PubMed  Google Scholar 

  23. Sehic E, Szekely M, Ungar AL, Oladehin A, Blatteis CM. Hypothalamic prostaglandin E2 during lipopolysaccharide-induced fever in guinea pigs. Brain Res Bull. 1996;39:391–9.

    Article  CAS  PubMed  Google Scholar 

  24. Sehic E, Ungar AL, Blatteis CM. Interaction between norepinephrine and prostaglandin E2 in the preoptic area of guinea pigs. Am J Physiol. 1996;271:R528–36.

    CAS  PubMed  Google Scholar 

  25. Netea MG, Kullberg BJ, Van Der Meer JW. Do only circulating pyrogenic cytokines act as mediators in the febrile response? A hypothesis. Eur J Clin Invest. 1999;29:351–6.

    Article  CAS  PubMed  Google Scholar 

  26. Campisi J, Hansen MK, O’Connor KA, Biedenkapp JC, Watkins LR, Maier SF, et al. Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge. J Appl Physiol. 2003;95:1873–82.

    Article  CAS  PubMed  Google Scholar 

  27. Roth J, Martin D, Storr B, Zeisberger E. Neutralization of pyrogen-induced tumour necrosis factor by its type 1 soluble receptor in guinea-pigs: effects on fever and interleukin-6 release. J Physiol. 1998;509:267–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Breder CD, Dinarello CA, Saper CB. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 1988;240:321–4.

    Article  CAS  PubMed  Google Scholar 

  29. Skarnes RC, Brown SK, Hull SS, McCracken JA. Role of prostaglandin E in the biphasic fever response to endotoxin. J Exp Med. 1981;154:1212–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Cavaillon JM, Fitting C, Haeffner-Cavaillon N. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol. 1990;20:253–7.

    Article  CAS  PubMed  Google Scholar 

  31. Feldberg W, Myers RD. A new concept of temperature regulation by amines in the hypothalamus. Nature. 1963;200:1325.

    Article  CAS  PubMed  Google Scholar 

  32. Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci. 1998;840:289–300.

    Article  CAS  PubMed  Google Scholar 

  33. Goldbach JM, Roth J, Zeisberger E. Fever suppression by subdiaphragmatic vagotomy in guinea pigs depends on the route of pyrogen administration. Am J Physiol. 1997;272:R675–81.

    CAS  PubMed  Google Scholar 

  34. Simons CT, Kulchitsky VA, Sugimoto N, Homer LD, Szekely M, Romanovsky AA. Signaling the brain in systemic inflammation: which vagal branch is involved in fever genesis? Am J Physiol. 1998;275:R63–8.

    CAS  PubMed  Google Scholar 

  35. Linthorst AC, Flachskamm C, Holsboer F, Reul JM. Intraperitoneal administration of bacterial endotoxin enhances noradrenergic neurotransmission in the rat preoptic area: relationship with body temperature and hypothalamic–pituitary–adrenocortical axis activity. Eur J Neurosci. 1995;7:2418–30.

    Article  CAS  PubMed  Google Scholar 

  36. Shido O, Romanovsky AA, Ungar AL, Blatteis CM. Role of intrapreoptic norepinephrine in endotoxin-induced fever in guinea pigs. Am J Physiol. 1993;265:R1369–75.

    CAS  PubMed  Google Scholar 

  37. Mackowiak PA. Concepts of fever. Arch Intern Med. 1998;158:1870–81.

    Article  CAS  PubMed  Google Scholar 

  38. Leon LR, Kozak W, Kluger MJ. Role of IL-10 in inflammation. Studies using cytokine knockout mice. Ann N Y Acad Sci. 1998;856:69–75.

    Article  CAS  PubMed  Google Scholar 

  39. Pittman QJ, Chen X, Mouihate A, Martin S. Vasopressin-induced antipyresis. Sex- and experience-dependent febrile responses. Ann N Y Acad Sci. 1998;856:53–61.

    Article  CAS  PubMed  Google Scholar 

  40. Carey F, Forder R, Edge MD, Greene AR, Horan MA, Strijbos PJ, et al. Lipocortin 1 fragment modifies pyrogenic actions of cytokines in rats. Am J Physiol. 1990;259:R266–9.

    CAS  PubMed  Google Scholar 

  41. Steiner AA, Antunes-Rodrigues J, McCann SM, Branco LG. Antipyretic role of the NO-cGMP pathway in the anteroventral preoptic region of the rat brain. Am J Physiol Regul Integr Comp Physiol. 2002;282:R584–93.

    Article  CAS  PubMed  Google Scholar 

  42. Ensor JE, Wiener SM, McCrea KA, Viscardi RM, Crawford EK, Hasday JD. Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-alpha expression. Am J Physiol. 1994;266:C967–74.

    CAS  PubMed  Google Scholar 

  43. Fouqueray B, Philippe C, Amrani A, Perez J, Baud L. Heat shock prevents lipopolysaccharide-induced tumor necrosis factor-alpha synthesis by rat mononuclear phagocytes. Eur J Immunol. 1992;22:2983–7.

    Article  CAS  PubMed  Google Scholar 

  44. Kappel M, Diamant M, Hansen MB, Klokker M, Pedersen BK. Effects of in vitro hyperthermia on the proliferative response of blood mononuclear cell subsets, and detection of interleukins 1 and 6, tumour necrosis factor-alpha and interferon-gamma. Immunology. 1991;73:304–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Snyder YM, Guthrie L, Evans GF, Zuckerman SH. Transcriptional inhibition of endotoxin-induced monokine synthesis following heat shock in murine peritoneal macrophages. J Leukoc Biol. 1992;51:181–7.

    CAS  PubMed  Google Scholar 

  46. Velasco S, Tarlow M, Olsen K, Shay JW, McCracken Jr GH, Nisen PD. Temperature-dependent modulation of lipopolysaccharide-induced interleukin-1 beta and tumor necrosis factor alpha expression in cultured human astroglial cells by dexamethasone and indomethacin. J Clin Invest. 1991;87:1674–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Jensen BN, Jensen FS, Madsen SN, Lossl K. Accuracy of digital tympanic, oral, axillary, and rectal thermometers compared with standard rectal mercury thermometers. Eur J Surg. 2000;166:848–51.

    Article  CAS  PubMed  Google Scholar 

  48. Erickson RS, Kirklin SK. Comparison of ear-based, bladder, oral, and axillary methods for core temperature measurement. Crit Care Med. 1993;21:1528–34.

    Article  CAS  PubMed  Google Scholar 

  49. Lefrant JY, Muller L, de La Coussaye JE, Benbabaali M, Lebris C, Zeitoun N, et al. Temperature measurement in intensive care patients: comparison of urinary bladder, oesophageal, rectal, axillary, and inguinal methods versus pulmonary artery core method. Intensive Care Med. 2003;29:414–8.

    Article  PubMed  Google Scholar 

  50. Schmitz T, Bair N, Falk M, Levine C. A comparison of five methods of temperature measurement in febrile intensive care patients. Am J Crit Care. 1995;4:286–92.

    CAS  PubMed  Google Scholar 

  51. Kiekkas P, Aretha D, Bakalis N, Karpouhtsi I, Marneras C, Baltopoulos GI. Fever effects and treatment in critical care: literature review. Aust Crit Care. 2013;26:130–5.

    Article  PubMed  Google Scholar 

  52. Siddiqui S, Razzak J. Early versus late pre-intensive care unit admission broad spectrum antibiotics for severe sepsis in adults. Cochrane Database Syst Rev. 2010(10):CD007081.

    Google Scholar 

  53. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.

    Article  PubMed  Google Scholar 

  54. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742–51.

    Article  PubMed  Google Scholar 

  55. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–74.

    Article  CAS  PubMed  Google Scholar 

  56. Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003;123:1615–24.

    Article  PubMed  Google Scholar 

  57. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.

    Article  PubMed  Google Scholar 

  58. Carlet J, Ben Ali A, Chalfine A. Epidemiology and control of antibiotic resistance in the intensive care unit. Curr Opin Infect Dis. 2004;17:309–16.

    Article  PubMed  Google Scholar 

  59. Dupuy AM, Philippart F, Pean Y, Lasocki S, Charles PE, Chalumeau M, et al. Role of biomarkers in the management of antibiotic therapy: an expert panel review: I—currently available biomarkers for clinical use in acute infections. Ann Intensive Care. 2013;3:22.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med. 1996;154:617–24.

    Article  CAS  PubMed  Google Scholar 

  61. Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis. 2006;42:1118–26.

    Article  PubMed  Google Scholar 

  62. Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med. 2012;38:1930–45.

    Article  PubMed  Google Scholar 

  63. Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33:1538–48.

    Article  PubMed  Google Scholar 

  64. Rello J, Ulldemolins M, Lisboa T, Koulenti D, Manez R, Martin-Loeches I, et al. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J. 2011;37:1332–9.

    Article  CAS  PubMed  Google Scholar 

  65. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867–903.

    Article  PubMed  Google Scholar 

  66. Torres A, El-Ebiary M, Soler N, Monton C, Fabregas N, Hernandez C. Stomach as a source of colonization of the respiratory tract during mechanical ventilation: association with ventilator-associated pneumonia. Eur Respir J. 1996;9:1729–35.

    Article  CAS  PubMed  Google Scholar 

  67. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143:1121–9.

    Article  CAS  PubMed  Google Scholar 

  68. Napolitano LM. Use of severity scoring and stratification factors in clinical trials of hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis. 2010;51 Suppl 1:S67–80.

    Google Scholar 

  69. Luyt CE, Chastre J, Fagon JY. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med. 2004;30:844–52.

    Article  PubMed  Google Scholar 

  70. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000;132:621–30.

    Article  CAS  PubMed  Google Scholar 

  71. Berton DC, Kalil AC, Teixeira PJ. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev. 2012;1:CD006482.

    Google Scholar 

  72. Gerbeaux P, Ledoray V, Boussuges A, Molenat F, Jean P, Sainty JM. Diagnosis of nosocomial pneumonia in mechanically ventilated patients: repeatability of the bronchoalveolar lavage. Am J Respir Crit Care Med. 1998;157:76–80.

    Article  CAS  PubMed  Google Scholar 

  73. Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006;355:2619–30.

    Article  Google Scholar 

  74. Muscedere J, Dodek P, Keenan S, Fowler R, Cook D, Heyland D. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: diagnosis and treatment. J Crit Care. 2008;23:138–47.

    Article  PubMed  Google Scholar 

  75. Burton DC, Edwards JR, Srinivasan A, Fridkin SK, Gould CV. Trends in catheter-associated urinary tract infections in adult intensive care units-United States, 1990–2007. Infect Control Hosp Epidemiol. 2011;32:748–56.

    Article  PubMed  Google Scholar 

  76. Clec’h C, Schwebel C, Francais A, Toledano D, Fosse JP, Garrouste-Orgeas M, et al. Does catheter-associated urinary tract infection increase mortality in critically ill patients? Infect Control Hosp Epidemiol. 2007;28:1367–73.

    Article  PubMed  Google Scholar 

  77. Shuman EK, Chenoweth CE. Recognition and prevention of healthcare-associated urinary tract infections in the intensive care unit. Crit Care Med. 2010;38:S373–9.

    Article  PubMed  Google Scholar 

  78. Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001;7:342–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.

    Article  PubMed  Google Scholar 

  80. Rosser CJ, Bare RL, Meredith JW. Urinary tract infections in the critically ill patient with a urinary catheter. Am J Surg. 1999;177:287–90.

    Article  CAS  PubMed  Google Scholar 

  81. Leone M, Albanese J, Garnier F, Sapin C, Barrau K, Bimar MC, et al. Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Intensive Care Med. 2003;29:1077–80.

    Article  PubMed  Google Scholar 

  82. Shigemura K, Tanaka K, Osawa K, Arakawa S, Miyake H, Fujisawa M. Clinical factors associated with shock in bacteremic UTI. Int Urol Nephrol. 2013;45:653–7.

    Article  PubMed  Google Scholar 

  83. Johnson S, Samore MH, Farrow KA, Killgore GE, Tenover FC, Lyras D, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med. 1999;341:1645–51.

    Article  CAS  PubMed  Google Scholar 

  84. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204–10.

    Article  CAS  PubMed  Google Scholar 

  85. Riddle DJ, Dubberke ER. Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am. 2009;23:727–43.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control. 2002;30:S1–46.

    Article  PubMed  Google Scholar 

  87. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235:363–72.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 1997;92:739–50.

    CAS  PubMed  Google Scholar 

  89. Koss K, Clark MA, Sanders DS, Morton D, Keighley MR, Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis. 2006;8:149–54.

    Article  CAS  PubMed  Google Scholar 

  90. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006;145:758–64.

    Article  PubMed  Google Scholar 

  91. Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44:1145–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Goldenberg SD, French GL. Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. J Hosp Infect. 2011;79:4–7.

    Article  CAS  PubMed  Google Scholar 

  93. Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loungnarath V, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56:67–73.

    Article  PubMed  Google Scholar 

  94. Kufelnicka AM, Kirn TJ. Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection. Clin Infect Dis. 2011;52:1451–7.

    Article  PubMed  Google Scholar 

  95. Micek ST, Schramm G, Morrow L, Frazee E, Personett H, Doherty JA, et al. Clostridium difficile infection: a multicenter study of epidemiology and outcomes in mechanically ventilated patients. Crit Care Med. 2013;41:1968–75.

    Article  PubMed  Google Scholar 

  96. Dodek PM, Norena M, Ayas NT, Romney M, Wong H. Length of stay and mortality due to Clostridium difficile infection acquired in the intensive care unit. J Crit Care. 2013;28:335–40.

    Article  PubMed  Google Scholar 

  97. Zahar JR, Schwebel C, Adrie C, Garrouste-Orgeas M, Francais A, Vesin A, et al. Outcome of ICU patients with Clostridium difficile infection. Crit Care. 2012;16:R215.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee. JAMA. 1995;274:639–44.

    Article  CAS  PubMed  Google Scholar 

  99. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect. 1996;33:23–32.

    Article  CAS  PubMed  Google Scholar 

  100. Chahoud J, Kanafani ZA, Kanj SS. Management of candidaemia and invasive candidiasis in critically ill patients. Int J Antimicrob Agents. 2013;42 Suppl:S29–35.

    Google Scholar 

  101. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3:685–702.

    Article  PubMed  Google Scholar 

  102. Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, et al. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis. 2010;10:150.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Blot S, Dimopoulos G, Rello J, Vogelaers D. Is Candida really a threat in the ICU? Curr Opin Crit Care. 2008;14:600–4.

    Article  PubMed  Google Scholar 

  104. Hassan I, Powell G, Sidhu M, Hart WM, Denning DW. Excess mortality, length of stay and cost attributable to candidaemia. J Infect. 2009;59:360–5.

    Article  CAS  PubMed  Google Scholar 

  105. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220:751–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34:730–7.

    Article  PubMed  Google Scholar 

  107. Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, et al. Systemic antifungal therapy in critically ill patients without invasive fungal infection*. Crit Care Med. 2012;40:813–22.

    Article  CAS  PubMed  Google Scholar 

  108. Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M. Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis. 2013;13:29.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Morace G, Borghi E. Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol. 2010;76:950–6.

    CAS  PubMed  Google Scholar 

  110. Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186:56–64.

    Article  PubMed  Google Scholar 

  111. Aarts MA, Brun-Buisson C, Cook DJ, Kumar A, Opal S, Rocker G, et al. Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome? Intensive Care Med. 2007;33:1369–78.

    Article  PubMed  Google Scholar 

  112. Circiumaru B, Baldock G, Cohen J. A prospective study of fever in the intensive care unit. Intensive Care Med. 1999;25:668–73.

    Article  CAS  PubMed  Google Scholar 

  113. Fanning J, Neuhoff RA, Brewer JE, Castaneda T, Marcotte MP, Jacobson RL. Frequency and yield of postoperative fever evaluation. Infect Dis Obstet Gynecol. 1998;6:252–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Shaw JA, Chung R. Febrile response after knee and hip arthroplasty. Clin Orthop Relat Res. 1999;367:181–9.

    Article  PubMed  Google Scholar 

  115. Miyawaki T, Maeda S, Koyama Y, Fukuoka R, Shimada M. Elevation of plasma interleukin-6 level is involved in postoperative fever following major oral and maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:146–52.

    Article  CAS  PubMed  Google Scholar 

  116. Frank SM, Kluger MJ, Kunkel SL. Elevated thermostatic setpoint in postoperative patients. Anesthesiology. 2000;93:1426–31.

    Article  CAS  PubMed  Google Scholar 

  117. Kim OY, Monsel A, Bertrand M, Cavaillon JM, Coriat P, Adib-Conquy M. Translocation of bacterial NOD2 agonist and its link with inflammation. Crit Care. 2009;13:R124.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M. Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res. 2003;9:101–7.

    Article  CAS  PubMed  Google Scholar 

  119. Lofmark R, Nordlander R, Orinius E. The temperature course in acute myocardial infarction. Am Heart J. 1978;96:153–6.

    Article  CAS  PubMed  Google Scholar 

  120. Naito K, Anzai T, Yoshikawa T, Maekawa Y, Sugano Y, Kohno T, et al. Increased body temperature after reperfused acute myocardial infarction is associated with adverse left ventricular remodeling. J Card Fail. 2007;13:25–33.

    Article  PubMed  Google Scholar 

  121. Fromm Jr RE. Cardiac troponins in the intensive care unit: common causes of increased levels and interpretation. Crit Care Med. 2007;35:584–8.

    Article  CAS  PubMed  Google Scholar 

  122. Klein Gunnewiek JM, van de Leur JJ. Elevated troponin T concentrations in critically ill patients. Intensive Care Med. 2003;29:2317–22.

    Article  PubMed  Google Scholar 

  123. Lim W, Qushmaq I, Cook DJ, Crowther MA, Heels-Ansdell D, Devereaux PJ. Elevated troponin and myocardial infarction in the intensive care unit: a prospective study. Crit Care. 2005;9:R636–44.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Calvo-Romero JM, Lima-Rodriguez EM, Perez-Miranda M, Bureo-Dacal P. Low-grade and high-grade fever at presentation of acute pulmonary embolism. Blood Coagul Fibrinolysis. 2004;15:331–3.

    Article  PubMed  Google Scholar 

  125. Kazmers A, Groehn H, Meeker C. Duplex examination of the inferior vena cava. Am Surg. 2000;66:986–9.

    CAS  PubMed  Google Scholar 

  126. Huffman JL, Schenker S. Acute acalculous cholecystitis: a review. Clin Gastroenterol Hepatol. 2010;8:15–22.

    Article  PubMed  Google Scholar 

  127. Jaramillo EJ, Trevino JM, Berghoff KR, Franklin Jr ME. Bedside diagnostic laparoscopy in the intensive care unit: a 13-year experience. JSLS. 2006;10:155–9.

    PubMed  PubMed Central  Google Scholar 

  128. Laurila J, Syrjala H, Laurila PA, Saarnio J, Ala-Kokko TI. Acute acalculous cholecystitis in critically ill patients. Acta Anaesthesiol Scand. 2004;48:986–91.

    Article  CAS  PubMed  Google Scholar 

  129. Pelinka LE, Schmidhammer R, Hamid L, Mauritz W, Redl H. Acute acalculous cholecystitis after trauma: a prospective study. J Trauma. 2003;55:323–9.

    Article  PubMed  Google Scholar 

  130. Geraghty PJ, Sanchez LA, Rubin BG, Choi ET, Flye MW, Curci JA, et al. Overt ischemic colitis after endovascular repair of aortoiliac aneurysms. J Vasc Surg. 2004;40:413–8.

    Article  PubMed  Google Scholar 

  131. Maldonado TS, Rockman CB, Riles E, Douglas D, Adelman MA, Jacobowitz GR, et al. Ischemic complications after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2004;40:703–9.

    Article  PubMed  Google Scholar 

  132. Theodorou P, Maurer CA, Spanholtz TA, Phan TQ, Amini P, Perbix W, et al. Acalculous cholecystitis in severely burned patients: incidence and predisposing factors. Burns. 2009;35:405–11.

    Article  CAS  PubMed  Google Scholar 

  133. Aldrete JS, Han SY, Laws HL, Kirklin JW. Intestinal infarction complicating low cardiac output states. Surg Gynecol Obstet. 1977;144:371–5.

    CAS  PubMed  Google Scholar 

  134. Trowbridge RL, Rutkowski NK, Shojania KG. Does this patient have acute cholecystitis? JAMA. 2003;289:80–6.

    Article  PubMed  Google Scholar 

  135. Bilgin YM, van de Watering LM, Brand A. Clinical effects of leucoreduction of blood transfusions. Neth J Med. 2011;69:441–50.

    CAS  PubMed  Google Scholar 

  136. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409–17.

    Article  CAS  PubMed  Google Scholar 

  137. Hayden SJ, Albert TJ, Watkins TR, Swenson ER. Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med. 2012;185:1049–57.

    Article  PubMed  Google Scholar 

  138. Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, et al. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion. 2002;42:1356–64.

    Article  PubMed  Google Scholar 

  139. Gilliss BM, Looney MR, Gropper MA. Reducing noninfectious risks of blood transfusion. Anesthesiology. 2011;115:635–49.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Klein HG, Dodd RY, Ness PM, Fratantoni JA, Nemo GJ. Current status of microbial contamination of blood components: summary of a conference. Transfusion. 1997;37:95–101.

    Article  CAS  PubMed  Google Scholar 

  141. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two part—blood transfusion. N Engl J Med. 1999;340:438–47.

    Article  CAS  PubMed  Google Scholar 

  142. Ness PM, Shirey RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion. 1990;30:688–93.

    Article  CAS  PubMed  Google Scholar 

  143. Shulman IA, Odono V. The risk of overt acute hemolytic transfusion reaction following the use of an immediate-spin crossmatch. Transfusion. 1994;34:87–8.

    Article  CAS  PubMed  Google Scholar 

  144. Shepherd GM. Hypersensitivity reactions to drugs: evaluation and management. Mt Sinai J Med. 2003;70:113–25.

    PubMed  Google Scholar 

  145. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology. 2005;209:123–9.

    Article  CAS  PubMed  Google Scholar 

  146. Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124:588–97.

    Article  CAS  PubMed  Google Scholar 

  147. Bruder N, Raynal M, Pellissier D, Courtinat C, Francois G. Influence of body temperature, with or without sedation, on energy expenditure in severe head-injured patients. Crit Care Med. 1998;26:568–72.

    Article  CAS  PubMed  Google Scholar 

  148. Manthous CA, Hall JB, Olson D, Singh M, Chatila W, Pohlman A, et al. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med. 1995;151:10–4.

    Article  CAS  PubMed  Google Scholar 

  149. Hammond NE, Boyle M. Pharmacological versus non-pharmacological antipyretic treatments in febrile critically ill adult patients: a systematic review and meta-analysis. Aust Crit Care. 2011;24:4–17.

    Article  CAS  PubMed  Google Scholar 

  150. Niven DJ, Laupland KB, Tabah A, Vesin A, Rello J, Koulenti D, et al. Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators’ survey. Crit Care. 2013;17:R289.

    Article  PubMed  PubMed Central  Google Scholar 

  151. Jefferies S, Weatherall M, Young P, Eyers S, Perrin KG, Beasley CR. The effect of antipyretic medications on mortality in critically ill patients with infection: a systematic review and meta-analysis. Crit Care Resusc. 2011;13:125–31.

    PubMed  Google Scholar 

  152. Young PJ, Saxena M, Beasley R, Bellomo R, Bailey M, Pilcher D, et al. Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med. 2012.

    Google Scholar 

  153. Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E, et al. Determinants of temperature abnormalities and influence on outcome of critical illness. Crit Care Med. 2012;40:145–51.

    Article  CAS  PubMed  Google Scholar 

  154. Egi M, Morita K. Fever in non-neurological critically ill patients: a systematic review of observational studies. J Crit Care. 2012;27:428–33.

    Article  PubMed  Google Scholar 

  155. Small PM, Tauber MG, Hackbarth CJ, Sande MA. Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits. Infect Immun. 1986;52:484–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  156. Kwiatkowski D. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. J Exp Med. 1989;169:357–61.

    Article  CAS  PubMed  Google Scholar 

  157. Villar J, Ribeiro SP, Mullen JB, Kuliszewski M, Post M, Slutsky AS. Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med. 1994;22:914–21.

    Article  CAS  PubMed  Google Scholar 

  158. Ahkee S, Srinath L, Ramirez J. Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis. South Med J. 1997;90:296–8.

    Article  CAS  PubMed  Google Scholar 

  159. Greenberg RS, Chen H, Hasday JD. Acetaminophen has limited antipyretic activity in critically ill patients. J Crit Care. 2010;25:363.e1–7.

    Article  CAS  Google Scholar 

  160. Niven DJ, Stelfox HT, Laupland KB. Antipyretic therapy in febrile critically ill adults: a systematic review and meta-analysis. J Crit Care. 2013;28:303–10.

    Article  PubMed  Google Scholar 

  161. Nunnally ME, Jaeschke R, Bellingan GJ, Lacroix J, Mourvillier B, Rodriguez-Vega GM, et al. Targeted temperature management in critical care: a report and recommendations from five professional societies. Crit Care Med. 2011;39:1113–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical-Surgical Intensive Care Medicine, Groupe Hospitalier Paris Saint Joseph, 185 rue R. Losserand, 75014, Paris, France

    François Philippart MD, PhD & Jean Carlet MD

  2. Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, QLD, Australia

    Alexis Tabah MD

  3. Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia

    Alexis Tabah MD

Authors
  1. François Philippart MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexis Tabah MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean Carlet MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to François Philippart MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Surgical Critical Care; Lahey Hospital and Medical Center, Division of Surgery, Burlington, Massachusetts, USA

    John M. O'Donnell

  2. Surgical Critical Care Medicine, Pr�-Card�o Hospital, Critical Care Medicine, University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil

    Flávio E. Nácul

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Philippart, F., Tabah, A., Carlet, J. (2016). Evaluation of the Febrile Patient in the Intensive Care Unit. In: O'Donnell, J., Nácul, F. (eds) Surgical Intensive Care Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-19668-8_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19668-8_32

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19667-1

  • Online ISBN: 978-3-319-19668-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation